This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Lancaster Colony (LANC) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Lancaster Colony (LANC) delivered earnings and revenue surprises of 11.48% and 0.83%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Mondelez (MDLZ) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Mondelez (MDLZ) delivered earnings and revenue surprises of 8.82% and 3.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Hain Celestial (HAIN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Hain Celestial (HAIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hain Celestial (HAIN) Q4 Earnings Miss Mark, Sales Rise Y/Y
by Zacks Equity Research
Hain Celestial (HAIN) reports soft results for fourth-quarter fiscal 2022. Several challenges, mainly in Europe, and unfavorable foreign currency translations hurt results.
Hain Celestial (HAIN) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Hain Celestial (HAIN) delivered earnings and revenue surprises of -70.37% and 0.37%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Things to Know Before Hain Celestial's (HAIN) Q4 Earnings
by Zacks Equity Research
Hain Celestial's (HAIN) fourth-quarter fiscal 2022 earnings might have been hurt by inflation, foreign currency headwinds and supply-chain disruptions.
Analysts Estimate Hain Celestial (HAIN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Hain Celestial (HAIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hain Celestial (HAIN) Issues Soft Preliminary Results for Q4
by Zacks Equity Research
Hain Celestial (HAIN) announces weak preliminary results for fourth-quarter fiscal 2022. Volatile backdrop in Europe and unfavorable currency movements hurt the results.
Hain Celestial's (HAIN) Q3 Earnings Miss Mark, Sales Rise Y/Y
by Zacks Equity Research
Hain Celestial (HAIN) reports weak performance in third-quarter fiscal 2022 on high inflations, supply-chain disruptions, ingredient and package shortages.
Hain Celestial (HAIN) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Hain Celestial (HAIN) delivered earnings and revenue surprises of -28.26% and 4.69%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Freshpet (FRPT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Freshpet (FRPT) delivered earnings and revenue surprises of -11.11% and 4.68%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Factors Influencing Constellation Brands' (STZ) Q4 Earnings
by Zacks Equity Research
Constellation Brands' (STZ) Q4 earnings are expected to have been hurt by soft wine & spirits, and higher costs. Strength in the beer business and premiumization efforts are likely to have aided.
Hain Celestial's (HAIN) Q2 Earnings Beat Estimates, Sales Soft
by Zacks Equity Research
Hain Celestial (HAIN) posts mixed results for second-quarter fiscal 2022. HAIN witnesses inflation, and industry-wide distribution and warehousing costs in the quarter.
Hain Celestial (HAIN) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Hain Celestial (HAIN) delivered earnings and revenue surprises of 9.09% and 0.67%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Food Stocks' Earnings Lineup on Feb 3: HSY, HAIN & POST
by Zacks Equity Research
Food stocks have been gaining on efforts to boost portfolio and favorable demand while high costs are a concern. Hershey (HSY), Hain Celestial (HAIN), and Post Holdings (POST) are due to report earnings.
Things to Know Before Hain Celestial's (HAIN) Q2 Earnings
by Zacks Equity Research
Hain Celestial's (HAIN) second-quarter fiscal 2022 results might have been hurt by high inflation, labor shortages, increased freight cost and major overlaps related to COVID-19.
Earnings Preview: Hain Celestial (HAIN) Q2 Earnings Expected to Decline
by Zacks Equity Research
Hain Celestial (HAIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Altria (MO) Benefits From Robust Pricing & RRP Expansion
by Zacks Equity Research
Altria (MO) is gaining on its strong pricing power and efforts to expand in the reduced risk products space amid weak cigarette volumes.
Mondelez (MDLZ) Gains on Buyouts, Pricing Amid High Costs
by Zacks Equity Research
Mondelez International (MDLZ) is focused on solidifying its portfolio through buyouts. Also, strength in emerging markets and pricing have been aiding it amid inflated costs.
Helen of Troy (HELE) Adds Osprey, Strengthens Leadership Brands
by Zacks Equity Research
Helen of Troy (HELE) closes the buyout of Osprey Packs. It is likely to be an addition to the company's Leadership Brands' portfolio and is expected to augment the top and bottom lines.
Nu Skin's (NUS) Transformational Strategies Keep It Well-Placed
by Zacks Equity Research
Nu Skin (NUS) gains on its solid customer base and network of sales leaders. The company's three transformational strategies also bode well amid pandemic-led disruptions.
Sysco (SYY) Looks Well-Placed for 2022 on Recipe for Growth
by Zacks Equity Research
Sysco (SYY) benefits from its Recipe for Growth program and away-from-home food demand amid escalated costs.
Forget Conagra Brands (CAG), Focus on These 3 Food Stocks for 2022
by Vrishali Bagree
Conagra Brands (CAG) looks troubled due to cost inflation. Food companies like Hain Celestial (HAIN), United Natural (UNFI) and Kellogg (K) look well placed for 2022 on the back of their strategic growth efforts.
Medifast (MED) Gains on OPTAVIA Strength, SG&A Costs Rise
by Zacks Equity Research
Medifast (MED) has been gaining on strength of its OPTAVIA lifestyle solution and coaching support system, which was a major driver in the third quarter.
Archer Daniels (ADM) Boosts Flavor Business Via Latest Buyout
by Zacks Equity Research
Archer Daniels' (ADM) recent acquisition of Flavor Infusion is set to help it expand the customer base across Latin America & the Caribbean along with drive growth in the highly-valued flavor space.